Synapse - Works

Results (4760)

Preliminary results from KEYNOTE-055: Pembrolizumab after platinum and cetuximab failure in head and neck squamous cell carcinoma (HNSCC)

Meeting Abstract

Bauml, J.; Seiwert, T. Y.; Pfister, D. G.; Worden, F. P.; Liu, S. V.; Gilbert, J.; Saba, N. F.; Weiss, J.; Wirth, L. J.; Sukari, A.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Clinical activity and safety of cobimetinib (cobi) and atezolizumab in colorectal cancer (CRC)

Meeting Abstract

Bendell, J. C.; Kim, T. W.; Goh, B. C.; Wallin, J.; Oh, D. Y.; Han, S. W.; Lee, C. B.; Hellmann, M. D.; Desai, J.; Lewin, J. H.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Identification of genetic test results with conflicting interpretations in prospective registry of multiplex testing (PROMPT)

Meeting Abstract

Balmana, J.; Digiovanni, L.; Gaddam, P.; Walsh, M. F.; Garber, J. E.; Couch, F. J.; Offit, K.; Robson, M. E.; Domchek, S. M.
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Phase 2 trial results of DN24-02, a HER2-targeted autologous cellular immunotherapy in HER2+ urothelial cancer patients (pts)

Meeting Abstract

Bajorin, D. F.; Sharma, P.; Quinn, D. I.; Plimack, E. R.; Hoffman-Censits, J. H.; O'Donnell, P. H.; Siefker-Radtke, A. O.; Sheikh, N. A.; Lill, J. S.; Trager, J. B.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Prevalence, risk factors, and sequelae of long-term chemotherapy-induced peripheral neuropathy (CIPN) among breast cancer survivors

Meeting Abstract

Bao, T.; Li, S. Q.; Mao, J. J.
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Phase (Ph) 1 study of oral seviteronel (VT-464), a dual CYP17-Lyase (L) inhibitor and androgen receptor (AR) antagonist, in patients (pts) with advanced AR plus triple negative (TNBC) or estrogen receptor (ER) plus breast cancer (BC)

Meeting Abstract

Bardia, A.; Dacosta, N. A.; Gabrail, N. Y.; Lemon, S.; Danso, M. A.; Ali, H. Y.; Fleming, R. A.; Kurman, M. R.; Eisner, J. R.; Moore, W. R.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Results of a randomized, double-blind placebo controlled phase 3 study evaluating idelalisib in combination with bendamustine and rituximab in patients with relapsed/refractory CLL and adverse prognostic features

Meeting Abstract

Barrientos, J. C.; Brown, J. R.; Atallah, E. L.; Coutre, S.; De La Serna, J.; Eradat, H. A.; Farber, C. M.; Janssens, A.; Loscertales, J.; Pocock, C.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Automated bone scan index as an imaging biomarker in metastatic castration resistant prostate cancer (mCRPC) patients treated with radium-223

Meeting Abstract

Anand, A.; Daignault, S.; Nordquist, L. T.; Ramos, J.; Jain, R. K.; McDonald, M.; Campbell, G.; George, S.; Albany, C.; Yu, E. Y.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Safety and clinical activity of durvalumab (MEDI4736), an anti-PD-L1 antibody, in treatment-naive patients with advanced non small-cell lung cancer

Meeting Abstract

Antonia, S. J.; Kim, S. W.; Spira, A. I.; Ahn, M. J.; Ou, S. H. I.; Stjepanovic, N.; Fasolo, A.; Jager, D.; Ott, P. A.; Wainberg, Z. A.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

A phase 1/2 study to evaluate safety and efficacy of nivolumab plus brentuximab vedotin in patients with CD30-expressing relapsed/refractory non-Hodgkin lymphomas (NHLs)

Meeting Abstract

Armand, P.; Brody, J.; Barr, P. M.; Shustov, A. R.; Moskowitz, A. J.; Kline, J. P.; Savage, K. J.; Kuruvilla, J.; Josephson, N. C.; Zinzani, P. L.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save